More News

27 May 2020 Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb
26 May 2020 Tetra Therapeutics Enters Into Definitive Merger Agreement To Be Acquired by Shionogi
26 May 2020 Merck to Acquire Themis
26 May 2020 Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801
25 May 2020 Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets
23 May 2020 AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly
20 May 2020 Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing
19 May 2020 Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases
18 May 2020 OSE Immunotherapeutics Presents CLEC-1, Novel Myeloid Immune Checkpoint Target for Cancer Immunotherapy
16 May 2020 LegoChem Biosciences and Iksuda Enter Licensing Agreement for Antibody Drug Conjugate Program
14 May 2020 Recursion Enters Into Global Licensing Agreement with Takeda to Develop TAK-733 in Hereditary Cancer Syndrome
14 May 2020 Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA...
13 May 2020 Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide
12 May 2020 Neurocrine Biosciences exercises option to license Idorsia's novel treatment for rare pediatric epilepsy
12 May 2020 Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration
08 May 2020 ACADIA Pharmaceuticals and Vanderbilt University Announce Exclusive License Agreement and Research Collaboration
07 May 2020 PTC Therapeutics to Acquire Censa Pharmaceuticals
07 May 2020 Mediolanum Farmaceutici Acquires the French Company ElsaLys Biotech to Develop Next Generation Immuno-oncology Therapies
06 May 2020 BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions
06 May 2020 Magenta Therapeutics and AVROBIO Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate as a Potential Conditioning Regimen for Lentiviral Gene Therapies
06 May 2020 Santhera Signs Agreements in Gene Therapy Research for Congenital Muscular Dystrophy with Rutgers University
05 May 2020 Alexion to Acquire Portola
04 May 2020 Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million
04 May 2020 Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark
04 May 2020 BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up